apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Adcimab 100 mg Injection 4 ml

  3. Adcimab 100 mg Injection 4 ml Substitute

Adcimab 100 mg Injection 4 ml Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

BEVACIZUMAB-100MG

Uses:

Adcimab 100 mg Injection 4 ml is used in the treatment of Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. The detailed uses of Adcimab 100 mg Injection 4 ml are as follows:<br/>• Colorectal Cancer: Adcimab 100 mg Injection 4 ml is used in combination with chemotherapy for metastatic cases.<br/>• Non-Small Cell Lung Cancer (NSCLC): Adcimab 100 mg Injection 4 ml helps slow tumor growth and spread when combined with carboplatin and paclitaxel.<br/>• Ovarian, Cervical, and Peritoneal Cancer: Adcimab 100 mg Injection 4 ml is often used post-surgery or with chemotherapy to improve outcomes.<br/>• Renal Cell Carcinoma (Kidney Cancer): Adcimab 100 mg Injection 4 ml enhances treatment efficacy when paired with other agents.<br/>• Glioblastoma (Brain Tumor): Adcimab 100 mg Injection 4 ml is approved for recurrent cases to reduce tumor vascularization.<br/>• Hepatocellular Carcinoma (Liver Cancer): Adcimab 100 mg Injection 4 ml is used in combination with other drugs for advanced stages.<br/>

Medicinal Benefits:

Adcimab 100 mg Injection 4 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Adcimab 100 mg Injection 4 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.

FAQs

Adcimab 100 mg Injection 4 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum.

Adcimab 100 mg Injection 4 ml works against a protein called vascular endothelial growth factor (VEGF). Inhibition of vascular endothelial growth factor (VEGF) limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thereby, Adcimab 100 mg Injection 4 ml helps treat cancer.

Adcimab 100 mg Injection 4 ml may reduce the number of red blood cells leading to anaemia. Its symptoms include pale skin, lack of energy, feeling breathless, feeling dizzy and lightheadedness.

Chemotherapy remains necessary. Adcimab 100 mg Injection 4 ml is given along with chemotherapy for treating cancer.

Adcimab 100 mg Injection 4 ml may increase the risk of bleeding and problems with wound healing. If you have had major surgery in the past 28days or if the wound hasn't healed, you should not take Adcimab 100 mg Injection 4 ml. Talk to your doctor for more information.

Cancer can affect anyone, though the risk increases with age. Individual risk is determined by factors such as smoking and drinking habits, lifestyle choices such as what you eat and exercise; a family history of cancer, and factors in your workplace and environment.

Adcimab 100 mg Injection 4 ml may increase the incidence of hypertension. Therefore, consult your doctor before taking Adcimab 100 mg Injection 4 ml if you have high blood pressure.

Adcimab 100 mg Injection 4 ml is given intravenously (into a vein) infusion by a healthcare professional. Adcimab 100 mg Injection 4 ml should never be given as an intravenous push or bolus. Do not self-administer.

The duration of treatment with Adcimab 100 mg Injection 4 ml depends on your condition and response to the treatment. Your doctor will decide the length of time, based on its effectiveness and your tolerance. Regular monitoring will guide ongoing treatment.

Chemotherapy targets and destroys rapidly dividing cells, including cancer cells, to stop their growth and spread. While, Adcimab 100 mg Injection 4 ml works by inhibiting the formation of new blood vessels that supply oxygen and nutrients to tumors. Cutting off this blood supply helps shrink the tumor or prevent it from growing further.

A person taking Adcimab 100 mg Injection 4 ml may still require chemotherapy. Adcimab 100 mg Injection 4 ml is often used in combination with chemotherapy to treat certain cancers, as it helps prevent tumor growth by blocking blood vessel formation and improves the effectiveness of chemotherapy.

Adcimab 100 mg Injection 4 ml causes side effects such as constipation, loss of appetite, fever, nose bleeds, change in speech, voice changes/hoarseness, and loss of body weight. Most of these side effects do not require any medical requirements as they will gradually reduce over time. Contact a doctor if these side effects persist for longer durations.